IvelinRadkov AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) stated {that a} Phase 3 examine of their antibody drug conjugate, or ADC, datopotamab deruxtecan didn’t present it…
Browsing: Phase
Krystal Biotech’s Jeune reports promising phase 1 data on wrinkles drug Source: (*1*)
(*3*) Palatin stock climbs 8% on Phase 3 testing update for PL9643 Source: Seekingalpha